Morteza Naghavi, M.D.
Founder, Board of Directors Member, and Scientific Advisory Board Member
Dr. Naghavi is an innovative medical doctor and researcher with interests in preventive cardiology, medical technology, and home healthcare.
graduated as a M.D. from Tehran University and was trained as a cardiovascular physician scientist under distinguished cardiologists Dr. S. Ward Casscells III and Dr. James T. Willerson at the Texas Heart Institute and the University of Texas Health Science Center
is internationally recognized as a leader in heart attack prevention initiatives.
Through his years of efforts in advancing the field of preventive cardiology, Dr. Naghavi founded the Society for Heart Attack Prevention and Eradication (SHAPE) and is the Executive Chairman of the SHAPE Task Force, an international non-profit coalition to overhaul the traditional (ineffective) methods of identifying individuals at risk of a near future heart attack.
In 2009, the SHAPE organization
helped pass Texas legislation HB1290 as the first heart attack preventive screening law in the United States.
Dr. Naghavi has a number of collaborative academic research projects including NIH and NSF funded studies.
has numerous publications in scientific journals, most notably two major consensus statements (Part I and Part II) and the SHAPE Guidelines.
He is also the editor of "Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment", the most comprehensive textbook on risk assessment of the Vulnerable Patient.
Along with academic activities, Dr. Naghavi is also an inventor and entrepreneur with over 30 patents and 5 companies one of which is listed on NASDAQ: VOLC.
He is currently the President and CEO of Fairway Medical Technologies and IN3 Ventures.
is passionate about transforming new ideas into healthcare solutions, and welcomes innovative proposals from physicians, engineers, and entrepreneurs.